To amend title XVIII of the Social Security Act to remove cost-sharing responsibilities for chronic care management services under the Medicare program.
Summary
HR8261, the Chronic Care Management Improvement Act of 2026, is an early-stage House bill eliminating Medicare beneficiary cost-sharing for chronic care management services starting January 2027. With only 2 cosponsors, referral to two committees, and zero direct federal spending, this bill is procedural at this stage. Market impact is minimal near-term; Medicare Advantage insurers and primary care providers with CCM programs are the structural beneficiaries if the bill advances.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8261 is procedural — referred to two committees with zero hearings scheduled
- 2.Zero direct federal spending — only changes coinsurance rules, not payment rates
- 3.Structural beneficiaries are Medicare Advantage insurers ($UNH, $CVS, $HUM) and primary care CCM providers if bill advances
- 4.Bill likely needs reintroduction in 120th Congress; very low near-term passage probability
- 5.CVS at $83.20 near 52-week high — recent momentum is not attributable to this early-stage bill
Market Implications
Near-term: negligible. This is a procedural bill with no scheduled committee action. The structural beneficiaries — Medicare Advantage insurers (, $CVS, $HUM) — show no discernible price impact from this bill's introduction. CVS ($83.20) is trading near its 52-week high with 15.85% 30-day momentum, but this is driven by factors unrelated to HR8261. No actionable trading signal exists at this stage. Medium-term (if bill advances to committee markup): Medicare Advantage insurers would see a modest utilization tailwind for CCM programs. Primary care-focused providers like Oak Street Health (CVS subsidiary) would benefit disproportionately. Monitor committee assignments — referral to both Energy and Commerce and Ways and Means creates a high bar. The 2-cosponsor total indicates limited coalition-building to date.
Full Analysis
HR8261 was introduced on April 14, 2026 by Rep. DelBene (D-WA) with Rep. Kelly (R-PA) as cosponsor, giving it nominal bipartisan cover. The bill was referred to both Energy and Commerce and Ways and Means — standard for Medicare Part B legislation. Status is early-stage with zero committee activity in the 16 days since introduction. The bill has only 2 cosponsors in a divided 119th Congress, indicating low legislative momentum.
The bill amends Section 1833 of the Social Security Act to set the Medicare Part B payment amount for chronic care management services at 100% of the allowed charge (currently 80% after beneficiary coinsurance) and waives the Part B deductible for these services. Importantly, this changes beneficiary cost-sharing, not provider payment rates — CBO would likely score this as zero net cost (beneficiary savings offset higher federal utilization spending, but no explicit appropriation is authorized). The effective date is January 1, 2027, giving the 120th Congress (2027-2029) time to implement if passed.
The structural winners are Medicare Advantage insurers (, $CVS/HUM) that can offer CCM services with no out-of-pocket barrier, potentially increasing enrollment and risk-adjustment data. Primary care chains like Oak Street Health (CVS), ChenMed, and Iora Health would also benefit from higher utilization. However, no committee markup is scheduled, and with the 119th Congress ending January 2027, this bill likely would need to be reintroduced in the 120th Congress to have any chance at passage.
CVS's stock closed at $83.20 on April 30, 2026, near its 52-week high of $85.15, with strong 30-day momentum (+15.85%). This upward move predates this bill and is more likely driven by earnings expectations or broader market rotation than this early-stage procedural action. No direct connection between CVS's price action and HR8261 should be inferred.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
What the bill does
Beneficiary cost-sharing elimination for chronic care management services under Medicare Part B
Who must act
Medicare beneficiaries enrolled in Part B, and Medicare Advantage plans administered by Aetna (CVS subsidiary)
What happens
Removes 20% coinsurance and Part B deductible for chronic care management codes; zero direct federal spending as payment rates are unchanged; reduces beneficiary financial barrier, potentially increasing CCM program enrollment and associated service utilization at Aetna network providers
Stock impact
CVS operates Aetna Medicare Advantage plans (~10% market share) and owns primary care assets including Oak Street Health, which directly provides chronic care management to Medicare patients. Increased CCM utilization would benefit Oak Street's risk-adjusted revenue model. Modest structural upside if bill advances
What the bill does
Beneficiary cost-sharing elimination for chronic care management services under Medicare Part B
Who must act
Medicare beneficiaries enrolled in Part B, and Medicare Advantage plans administered by Humana
What happens
Removes 20% coinsurance and Part B deductible for chronic care management codes; zero direct federal spending as payment rates are unchanged; higher CCM utilization would improve member engagement and risk adjustment data collection for Humana's MA population
Stock impact
Humana has the highest proportional exposure to Medicare Advantage among major insurers (~84% of premiums from government lines, primarily MA). Chronic care management volume growth directly supports Humana's risk adjustment revenue model. Small tailwind if bill progresses
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Protecting Health Care and Lowering Costs Act of 2025
Association Health Plans Act
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
I CAN Act
Veterans’ ACCESS Act of 2025
Protecting Health Care and Lowering Costs Act
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.